CRIS

Permanent URI for this communityhttps://investigadores.udd.cl/handle/123456789/1

Browse

Search Results

Now showing 1 - 10 of 28
  • Some of the metrics are blocked by your 
    Item type:Publication,
    EFFECTIVENESS AND SAFETY OF THE TETRAVALENT TAK-003 DENGUE VACCINE: A SYSTEMATIC REVIEW
    (2024)
    Ramos-rojas José
    ;
    Bengolea, Agustin
    ;
    Scigliano, Clara
    ;
    ;
    Catalano Hugo N.
      1
  • Some of the metrics are blocked by your 
    Item type:Publication,
    A Comparative Analysis of Universal and Sentinel Surveillance Data for Coronavirus Disease 2019: Insights From Argentina, Chile, and Mexico (2020–2022)
    (Oxford University Press (OUP), 2025-03-10)
    Lidia Redondo-Bravo
    ;
    Kinda Zureick
    ;
    Carla Voto
    ;
    Xaviera Molina Avendaño
    ;
    Laura Flores-Cisneros
    Scopus© Citations 2  5
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Latin America Cutaneous Oncology Management (LACOM) I: The Role of Skin Care in Oncology Patients and Survivors
    (SanovaWorks, 2025-02-01)
    Daniel Alcalá Pérez
    ;
    Ana Sofia Acosta Madiedo
    ;
    Sebastian Andreani
    ;
    Anneke Andriessen
    ;
    Hebert Cárdenas
      2
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Efectividad y seguridad de la vacuna recombinante para herpes zóster en diferentes poblaciones: revisión sistemática y metaanálisis
    (2024-01-01)
    Bengolea, Agustín
    ;
    Chamorro, Florencia
    ;
    Ramos, José T.
    ;
    ;
    Catalano, Hugo N.
    Varicella-zoster virus infections have increased globally, with complications such as postherpetic neuralgia and neurological sequelae. The recombinant vaccine against herpes zoster is proposed as a preventive strategy. This systematic review evaluates its effectiveness and safety in healthy and high-risk populations. A systematic review of randomized controlled trials comparing the effectiveness and safety of the vaccine was conducted. The search was carried out in Epistemonikos. Two researchers independently assessed the eligibility of the studies and the risk of bias was evaluated using the Cochrane Risk of Bias 2 tool. A meta-analysis of homogeneous results was conducted, and the certainty of the evidence was evaluated using GRADE. A minimally contextualized approach was adopted using predetermined thresholds. Nine randomized controlled trials were selected. The vaccine demonstrated a significant reduction in the incidence of herpes zoster in high-risk populations (risk difference of 140 fewer per 1000) with high certainty. However, in healthy populations, the effect was trivial (28 fewer per 1000). No significant differences were observed in postherpetic neuralgia in any of the populations analyzed. Adverse events increased in both populations, though no discrepancies in serious adverse events were noted. In high-risk populations, where the incidence of herpes zoster and its complications is higher, the vaccine demonstrated effectiveness in lowering the incidence of the disease, though not in that of postherpetic neuralgia. Conversely, in healthy populations, the impact of the vaccine was trivial. Individualized and informed recommendations are crucial when considering this vaccine.
    Scopus© Citations 2  2
  • Some of the metrics are blocked by your 
    Item type:Publication,
      6Scopus© Citations 1
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Setting up regional diagnostic reference levels for pediatric computed tomography in Latin America: preliminary results, challenges and the work ahead
    (2023)
    Lina Cadavid
    ;
    Lina Karout
    ;
    Mannudeep K. Kalra
    ;
    Flavio Morgado
    ;
    María Antonieta Londoño
    Scopus© Citations 4  2
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Minimally Invasive Surgery for Traumatic Thoracolumbar Fractures: A Cross-Sectional Study of Spine Surgeons
    (2023)
    Guillermo A. Ricciardi
    ;
    Juan Ignacio Cirillo Totera
    ;
    Juan P. Cabrera
    ;
    Alfredo Guiroy
    ;
    Charles A. Carazzo
      7Scopus© Citations 3
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Biosimilars approvals by thirteen regulatory authorities: A cross-national comparison
    (2023)
    Fernanda Lacerda da Silva Machado
    ;
    Martín Cañás
    ;
    Svetlana V. Doubova
    ;
    Martín A. Urtasun
    ;
    Gustavo H. Marín
    Scopus© Citations 9  1
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Corporate Networks and Business Groups in <scp>A</scp>rgentina in the Early 1970s
    (2014)
    Andrea Lluch
    ;
    ;
    María Inés Barbero
    <jats:p>This article examines the interlocking directorates' structure of prominent Argentine business groups at the end of the import substitution period (1970–72), identifying corporate relations among and between business groups and the largest companies, during a period characterised by high institutional and macroeconomic instability. Applying social network analysis, it seeks to clarify how business groups can contribute to the cohesion of a corporate network structure, through their ability to create links among firms not only within their boundaries but also external to them. The article contributes to both corporate network and business groups' literature, highlighting a role of business groups that extant literature has failed to identify as relevant.</jats:p>
      3  1Scopus© Citations 13
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Frontotemporal Dementias in Latin America: History, Epidemiology, Genetics, and Clinical Research
    (2021)
    Jorge J. Llibre-Guerra
    ;
    ;
    Mirna Lie Hosogi
    ;
    Lucia Montero
    ;
    Teresa Torralva
    <jats:p><jats:bold>Introduction:</jats:bold> The historical development, frequency, and impact of frontotemporal dementia (FTD) are less clear in Latin America than in high-income countries. Although there is a growing number of dementia studies in Latin America, little is known collectively about FTD prevalence studies by country, clinical heterogeneity, risk factors, and genetics in Latin American countries.</jats:p><jats:p><jats:bold>Methods:</jats:bold> A systematic review was completed, aimed at identifying the frequency, clinical heterogeneity, and genetics studies of FTD in Latin American populations. The search strategies used a combination of standardized terms for FTD and related disorders. In addition, at least one author per Latin American country summarized the available literature. Collaborative or regional studies were reviewed during consensus meetings.</jats:p><jats:p><jats:bold>Results:</jats:bold> The first FTD reports published in Latin America were mostly case reports. The last two decades marked a substantial increase in the number of FTD research in Latin American countries. Brazil (165), Argentina (84), Colombia (26), and Chile (23) are the countries with the larger numbers of FTD published studies. Most of the research has focused on clinical and neuropsychological features (<jats:italic>n</jats:italic> = 247), including the local adaptation of neuropsychological and behavioral assessment batteries. However, there are little to no large studies on prevalence (<jats:italic>n</jats:italic> = 4), biomarkers (<jats:italic>n</jats:italic> = 9), or neuropathology (<jats:italic>n</jats:italic> = 3) of FTD.</jats:p><jats:p><jats:bold>Conclusions:</jats:bold> Future FTD studies will be required in Latin America, albeit with a greater emphasis on clinical diagnosis, genetics, biomarkers, and neuropathological studies. Regional and country-level efforts should seek better estimations of the prevalence, incidence, and economic impact of FTD syndromes.</jats:p>
    Scopus© Citations 10  1